Mark A. Exley

12.7k total citations · 3 hit papers
124 papers, 10.3k citations indexed

About

Mark A. Exley is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Mark A. Exley has authored 124 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Immunology, 33 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Mark A. Exley's work include Immune Cell Function and Interaction (102 papers), T-cell and B-cell Immunology (77 papers) and CAR-T cell therapy research (32 papers). Mark A. Exley is often cited by papers focused on Immune Cell Function and Interaction (102 papers), T-cell and B-cell Immunology (77 papers) and CAR-T cell therapy research (32 papers). Mark A. Exley collaborates with scholars based in United States, United Kingdom and Japan. Mark A. Exley's co-authors include Steven P. Balk, Steven A. Porcelli, Jorge A. García, Richard S. Blumberg, Lydia Lynch, Donal O’Shea, Angela Shaulov, Jack L. Strominger, S. Brian Wilson and Margaret James Koziel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark A. Exley

120 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis

2004 600 citations Ivan J. Fuss, Frank Heller et al. Journal of Clinical Investigation profile →
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes

1998 550 citations S. Brian Wilson, Mark A. Exley et al. profile →
Multiple immuno-regulatory defects in type-1 diabetes

2002 547 citations Anjli Kukreja, John Marker et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Exley United States	56	8.0k	1.8k	1.5k	1.4k	1.2k	124	10.3k
Ciriaco A. Piccirillo Canada	54	9.5k 1.2×	2.1k 1.2×	1.2k 0.8×	1.7k 1.2×	1.9k 1.6×	145	13.2k
Barbara Fazekas de St Groth Australia	45	9.5k 1.2×	1.6k 0.9×	903 0.6×	744 0.5×	1.4k 1.1×	130	11.8k
Angela M. Thornton United States	39	8.8k 1.1×	1.7k 1.0×	859 0.6×	889 0.6×	1.6k 1.3×	66	11.2k
Jason D. Fontenot United States	23	14.3k 1.8×	2.5k 1.5×	1.3k 0.9×	1.4k 1.0×	2.0k 1.7×	39	17.0k
Franck J. Barrat United States	41	7.8k 1.0×	1.2k 0.7×	1.1k 0.7×	796 0.6×	2.0k 1.7×	66	11.0k
Hervé Groux France	41	7.0k 0.9×	1.3k 0.7×	1.2k 0.8×	778 0.5×	1.7k 1.5×	79	10.6k
Carola G. Vinuesa Australia	54	11.2k 1.4×	1.7k 1.0×	992 0.7×	983 0.7×	2.9k 2.4×	117	14.8k
Paul Lehmann United States	40	5.7k 0.7×	794 0.5×	940 0.6×	1.6k 1.1×	1.4k 1.2×	167	8.6k
Takeshi Takahashi Japan	41	8.5k 1.1×	2.6k 1.5×	651 0.4×	1.1k 0.8×	1.7k 1.4×	146	11.8k
Fred Ramsdell United States	38	12.7k 1.6×	2.1k 1.2×	831 0.6×	1.9k 1.3×	2.6k 2.2×	57	15.3k

Countries citing papers authored by Mark A. Exley

Since Specialization

Citations

This map shows the geographic impact of Mark A. Exley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Exley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Exley more than expected).

Fields of papers citing papers by Mark A. Exley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Exley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Exley. The network helps show where Mark A. Exley may publish in the future.

Co-authorship network of co-authors of Mark A. Exley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Exley. A scholar is included among the top collaborators of Mark A. Exley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Exley. Mark A. Exley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Exley, Mark A., Phillip Friedlander, Nadia Alatrakchi, et al.. (2017). Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial. Clinical Cancer Research. 23(14). 3510–3519. 126 indexed citations

Clancy‐Thompson, Eleanor, Lestat R. Ali, Patrick T. Bruck, et al.. (2017). IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells. Cancer Immunology Research. 6(1). 25–35. 24 indexed citations

Gilham, David E., John Anderson, John S. Bridgeman, et al.. (2015). Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015. Human Gene Therapy. 26(5). 276–285. 15 indexed citations

Subramanian, Meenakshi, Radhika Kini, Manasa Madasu, et al.. (2014). Extracellular adenosine controls NKT‐cell‐dependent hepatitis induction. European Journal of Immunology. 44(4). 1119–1129. 13 indexed citations

Nowak-Machen, Martina, Moritz Schmelzle, Dusan Hanidziar, et al.. (2013). Pulmonary Natural Killer T Cells Play an Essential Role in Mediating Hyperoxic Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 48(5). 601–609. 33 indexed citations

Nowak, Michael, Adrian Tun-Kyi, Ingo G.H. Schmidt‐Wolf, et al.. (2010). Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide. PLoS ONE. 5(6). e11311–e11311. 55 indexed citations

Teng, Michele W.L., Simon Yue, Janelle Sharkey, Mark A. Exley, & Mark J. Smyth. (2009). CD1d Activation and Blockade: A New Antitumor Strategy. The Journal of Immunology. 182(6). 3366–3371. 18 indexed citations

Kenna, Tony, Margaret O’Brien, Andrew E. Hogan, et al.. (2006). CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver. Cancer Immunology Immunotherapy. 56(4). 563–572. 13 indexed citations

Fuss, Ivan J., Frank Heller, Monica Boirivant, et al.. (2004). Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. Journal of Clinical Investigation. 113(10). 1490–1497. 600 indexed citations breakdown →

10.

Durante‐Mangoni, Emanuele, Ruojie Wang, Angela Shaulov, et al.. (2004). Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells. The Journal of Immunology. 173(3). 2159–2166. 106 indexed citations

11.

Balgansuren, Gansuvd, William J. Hubbard, Anne Hutchings, et al.. (2003). Phenotypic and Functional Characterization of Long-Term Cultured Rhesus Macaque Spleen-Derived NKT Cells. The Journal of Immunology. 171(6). 2904–2911. 22 indexed citations

12.

Huber, Sally A., Danielle Sartini, & Mark A. Exley. (2003). Role of CD1d in Coxsackievirus B3-Induced Myocarditis. The Journal of Immunology. 170(6). 3147–3153. 72 indexed citations

13.

Kukreja, Anjli, John Marker, Chenhui Zhang, et al.. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation. 109(1). 131–140. 28 indexed citations

14.

Kukreja, Anjli, John Marker, Chenhui Zhang, et al.. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation. 109(1). 131–140. 497 indexed citations

15.

Exley, Mark A., et al.. (2002). Cutting Edge: Compartmentalization of Th1-Like Noninvariant CD1d-Reactive T Cells in Hepatitis C Virus-Infected Liver. The Journal of Immunology. 168(4). 1519–1523. 113 indexed citations

16.

Tahir, Syed Muhammad, Olivia Cheng, Angela Shaulov, et al.. (2001). Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer. The Journal of Immunology. 167(7). 4046–4050. 320 indexed citations

17.

Dao, Tao, Mark A. Exley, Wajahat Z. Mehal, et al.. (2001). Involvement of CD1 in Peripheral Deletion of T Lymphocytes Is Independent of NK T Cells. The Journal of Immunology. 166(5). 3090–3097. 15 indexed citations

18.

Sonoda, Koh‐Hei, Douglas E. Faunce, Masaru Taniguchi, et al.. (2001). NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance. The Journal of Immunology. 166(1). 42–50. 195 indexed citations

19.

Exley, Mark A., Syed Muhammad Tahir, Olivia Cheng, et al.. (2001). Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses. The Journal of Immunology. 167(10). 5531–5534. 127 indexed citations

20.

Fox, Barbara S., Kathleen M. Kantak, Melissa A. Edwards, et al.. (1996). Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Medicine. 2(10). 1129–1132. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact